Gross Profit - Accelerate Diagnostics Inc (NASDAQ:AXDX) - Alpha Spread

Accelerate Diagnostics Inc
NASDAQ:AXDX

Watchlist Manager
Accelerate Diagnostics Inc Logo
Accelerate Diagnostics Inc
NASDAQ:AXDX
Watchlist
Price: 1.476 USD 0.41%
Market Cap: 34.9m USD
Have any thoughts about
Accelerate Diagnostics Inc?
Write Note

Accelerate Diagnostics Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Accelerate Diagnostics Inc
Gross Profit Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Accelerate Diagnostics Inc
NASDAQ:AXDX
Gross Profit
$3.3m
CAGR 3-Years
-9%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Gross Profit
$9B
CAGR 3-Years
4%
CAGR 5-Years
2%
CAGR 10-Years
8%
Boston Scientific Corp
NYSE:BSX
Gross Profit
$10.5B
CAGR 3-Years
12%
CAGR 5-Years
8%
CAGR 10-Years
8%
Stryker Corp
NYSE:SYK
Gross Profit
$13.7B
CAGR 3-Years
9%
CAGR 5-Years
8%
CAGR 10-Years
8%
Abbott Laboratories
NYSE:ABT
Gross Profit
$22.6B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Gross Profit
$5.1B
CAGR 3-Years
13%
CAGR 5-Years
13%
CAGR 10-Years
14%

See Also

What is Accelerate Diagnostics Inc's Gross Profit?
Gross Profit
3.3m USD

Based on the financial report for Jun 30, 2024, Accelerate Diagnostics Inc's Gross Profit amounts to 3.3m USD.

What is Accelerate Diagnostics Inc's Gross Profit growth rate?
Gross Profit CAGR 5Y
3%

Over the last year, the Gross Profit growth was 3%. The average annual Gross Profit growth rates for Accelerate Diagnostics Inc have been -9% over the past three years , 3% over the past five years .

Back to Top